{
  "question_stem": {
    "en": "A 38-year-old woman comes to the office due to progressively worsening exertional dyspnea. She used to jog frequently, but now becomes short of breath while grocery shopping. The patient has no other significant medical history and takes no medications. She smokes a half pack of cigarettes daily and does not use alcohol or illicit drugs. Blood pressure is 124/76 mm Hg, pulse is 78/min, and respirations are 20/min. Pulse oximetry shows 89% on room air. BMI is 27 kg/m². Cardiac examination is unremarkable. The chest is hyperresonant to percussion. Laboratory studies show markedly decreased serum alpha-1 antitrypsin levels {{exhibit_1}}. Which of the following pulmonary function test patterns is most likely to be present in this patient?",
    "zh": "一位38岁的女性因进行性加重的劳力性呼吸困难前来就诊。她过去经常慢跑，但现在在购物时就会出现呼吸短促。患者无其他重要病史，未服用任何药物。她每天吸半包烟，不饮酒也不使用违禁药物。血压为124/76 mmHg，脉搏78次/分钟，呼吸20次/分钟。脉搏血氧饱和度显示为89%。BMI为27 kg/m²。心脏检查无异常。胸部叩诊呈过清音。实验室检查显示血清α-1抗胰蛋白酶水平显着降低 {{exhibit_1}}。该患者最有可能出现以下哪种肺功能检查模式？"
  },
  "question": {
    "en": "Which of the following pulmonary function test patterns is most likely to be present in this patient?",
    "zh": "该患者最有可能出现以下哪种肺功能检查模式？"
  },
  "options": {
    "A": {
      "en": "Forced expiratory volume in 1 sec/forced vital capacity: ↓; Total lung capacity: ↑; Diffusing capacity for carbon monoxide: ↑",
      "zh": "1秒用力呼气量/用力肺活量：↓；肺总量：↑；一氧化碳弥散量：↑"
    },
    "B": {
      "en": "Forced expiratory volume in 1 sec/forced vital capacity: ↓; Total lung capacity: ↑; Diffusing capacity for carbon monoxide: ↓",
      "zh": "1秒用力呼气量/用力肺活量：↓；肺总量：↑；一氧化碳弥散量：↓"
    },
    "C": {
      "en": "Forced expiratory volume in 1 sec/forced vital capacity: Normal; Total lung capacity: Normal; Diffusing capacity for carbon monoxide: Normal",
      "zh": "1秒用力呼气量/用力肺活量：正常；肺总量：正常；一氧化碳弥散量：正常"
    },
    "D": {
      "en": "Forced expiratory volume in 1 sec/forced vital capacity: Normal; Total lung capacity: ↓; Diffusing capacity for carbon monoxide: Normal",
      "zh": "1秒用力呼气量/用力肺活量：正常；肺总量：↓；一氧化碳弥散量：正常"
    },
    "E": {
      "en": "Forced expiratory volume in 1 sec/forced vital capacity: Normal; Total lung capacity: ↓; Diffusing capacity for carbon monoxide: ↓",
      "zh": "1秒用力呼气量/用力肺活量：正常；肺总量：↓；一氧化碳弥散量：↓"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "A1AT deficiency. A1AT is a serum protein secreted by the liver that inhibits proteolytic enzymes (particularly neutrophil elastase) released by inflammatory cells. The lungs use A1AT to inhibit low levels of naturally occurring proteolysis. Without A1AT, these proteolytic enzymes go unchecked, causing emphysematous destruction of alveoli and the surrounding tissue, typically in a panacinar pattern.\n\nCharacteristic pulmonary test findings of emphysema (from any cause) include:\n\n*   Decreased FEV1/FVC (ie, an obstructive ratio [≤0.7]) due to significant airflow obstruction by narrow and floppy airways (loss of supporting elastin reduces the radial traction that holds small airways open).\n*   Increased residual volume due to incomplete lung emptying (air trapping) and elevated total lung capacity (TLC) due to emphysematous tissue destruction with subsequent airspace enlargement.\n*   Diffusing capacity of the lung for carbon monoxide (DLCO) tends to be reduced due to destruction of the alveolar capillary beds (decreased surface area available for gas exchange).\n\nThe development of emphysema (eg, hyperresonance) in these patients is greatly accelerated by cigarette smoking: even in the absence of smoking, patients with A1AT deficiency typically develop early-onset emphysema prior to age 50.\n\n(Choice A) Asthma is another obstructive lung disease that presents with reduced FEV1/FVC; although TLC can also be increased due to lung hyperinflation, it is more characteristic of COPD (extensive tissue destruction). In contrast to COPD, patients with asthma sometimes develop a high DLCO (increased negative intrathoracic pressure during inspiration increases pulmonary capillary blood volume, causing additional gas uptake).\n\n(Choice C) Pulmonary arterial hypertension presents with reduced DLCO in the setting of normal spirometry and lung volumes, as the poor pulmonary capillary blood flow impairs the lungs’ ability to extract oxygen (reduced DLCO); the airways and lung parenchyma are unaffected, resulting in intact lung mechanics (normal FEV1/FVC ratio and TLC).\n\n(Choices D and E) Restrictive processes demonstrate reduced lung volumes (eg, low TLC) with a normal or an increased FEV1/FVC ratio (although FEV1 and FVC are reduced individually). The DLCO differentiates *intrinsic* restriction (eg, interstitial lung disease) from *extrinsic* restriction (eg, kyphosis, neuromuscular disease): it is decreased in the former (thickened basement membrane) and normal in the latter.\n\nEducational objective:\nAlpha-1 antitrypsin deficiency can induce early-onset emphysema, which is further accelerated by smoking. Emphysema is characterized by expiratory airflow obstruction (decreased FEV1/FVC ratio), airspace enlargement and hyperinflation (increased total lung capacity), and a decreased diffusing capacity due to loss of alveolar surface area. {{exhibit_2}} {{exhibit_3}}",
    "zh": "α1AT缺乏症。 α1AT是一种由肝脏分泌的血清蛋白，可抑制炎症细胞释放的蛋白水解酶（特别是中性粒细胞弹性蛋白酶）。肺部利用α1AT来抑制低水平的自然发生的蛋白水解。没有α1AT，这些蛋白水解酶就会不受控制，导致肺泡和周围组织的肺气肿破坏，通常呈全小叶型。\n\n肺气肿（由任何原因引起）的特征性肺部检查结果包括：\n\n*   FEV1/FVC 降低（即阻塞性比率 [≤0.7]），这归因于气道狭窄和松弛（支持弹性蛋白的缺失降低了保持小气道开放的径向牵引力）造成的显着气流阻塞。\n*   残气量增加，这是由于肺部未完全排空（气体滞留）和肺总量 (TLC) 升高，这归因于肺气肿组织破坏，随后导致气腔扩大。\n*   肺一氧化碳弥散量 (DLCO) 往往降低，这归因于肺泡毛细血管床的破坏（可用于气体交换的表面积减少）。\n\n吸烟会大大加速这些患者肺气肿的发展（例如，过清音）：即使在不吸烟的情况下，α1AT缺乏症患者通常也会在50岁之前发展为早发性肺气肿。\n\n（选项 A）哮喘是另一种阻塞性肺病，表现为 FEV1/FVC 降低；尽管 TLC 也可能因肺过度充气而增加，但这更像是慢性阻塞性肺病（COPD）（广泛的组织破坏）。与 COPD 相比，哮喘患者有时会出现高 DLCO（吸气时负性胸内压增加，导致肺毛细血管血容量增加，从而导致额外的气体吸收）。\n\n（选项 C）肺动脉高压在正常肺活量测定和肺容量的情况下出现 DLCO 降低，因为不良的肺毛细血管血流会损害肺提取氧气的能力（DLCO 降低）；气道和肺实质不受影响，从而导致肺部力学完整（FEV1/FVC 比率和 TLC 正常）。\n\n（选项 D 和 E）限制性过程显示肺容量降低（例如，低 TLC），而 FEV1/FVC 比率正常或增加（尽管 FEV1 和 FVC 均单独降低）。 DLCO 区分了*内在*限制（例如，间质性肺病）和*外在*限制（例如，脊柱后凸，神经肌肉疾病）：前者降低（基底膜增厚），后者正常。\n\n教育目标：\nα-1 抗胰蛋白酶缺乏症可诱发早发性肺气肿，而吸烟会进一步加速肺气肿。肺气肿的特征是呼气气流阻塞（FEV1/FVC 比率降低）、气腔扩大和过度充气（肺总量增加）以及由于肺泡表面积减少而导致弥散能力下降。{{exhibit_2}} {{exhibit_3}}"
  },
  "summary": {
    "en": "This question tests knowledge of alpha-1 antitrypsin deficiency and its effect on pulmonary function tests, specifically the characteristic findings of emphysema. It requires understanding of obstructive lung disease patterns and how they manifest in pulmonary function testing.\n\nTo solve this question, recognize the patient's risk factors (smoking, A1AT deficiency) and the resulting emphysema. Recall the classic PFT pattern for emphysema: decreased FEV1/FVC, increased total lung capacity, and decreased diffusing capacity.",
    "zh": "本题考察对α-1抗胰蛋白酶缺乏症及其对肺功能检查的影响的了解，特别是肺气肿的特征性表现。它要求理解阻塞性肺病模式以及它们在肺功能检查中的表现。\n\n要解决这个问题，需要认识到患者的危险因素（吸烟，α1AT缺乏症）和由此产生的肺气肿。回忆肺气肿的经典 PFT 模式：FEV1/FVC 降低，肺总量增加，弥散量降低。"
  },
  "tags": "Alpha-1 antitrypsin deficiency; Emphysema; Pulmonary function tests; Obstructive lung disease; Respiratory medicine",
  "category": "Chest",
  "question_id": "1919",
  "has_exhibits": true,
  "exhibit_count": 3,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg",
    "image3.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Chest 23\\1919",
  "extracted_at": "2025-11-05T11:42:06.577731",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:37:21.769694",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}